Monday, May 21, 2018

Radiation Therapy_Cancer Therapy 2018

#Radiationtherapy is the most primary #treatment given to #cancer patients of all types. To know more about the different #therapies administered for #cancerpatients, join the "3rd World Congress on
Advanced Cancer Science & Therapy"on #October15-16 at #Osaka, Japan
https://tinyurl.com/ya6a5d5z

Beautiful city of Japan_OSAKA

An opportunity to explore the beautiful city of Japan-OSAKA.


Osaka is Japan’s second largest metropolitan area next to Tokyo. It is a large port city and commercial center and it remained to be the economic powerhouse for many centuries. Apart from its attractions like Universal Studios, temples, Osaka Castle, skyscraper, museum, Bay area and parks, Osaka is also famous for its Universities which have medical faculties making advances in regenerative medicine.


Plan a trip to #Osaka and explore the beauty of the city and add some points to your knowledge in #cancer as well.https://tinyurl.com/yd2oegty

Join us ta Osaka for the #CancerTherapy conference, "3rd World Congress on Advanced Cancer Science & Therapy" during October 15-16, 2018


Thursday, May 17, 2018

Radiation Therapy

#Radiationtherapy uses high energy radiations to kill #cancercells by damaging their #DNA. This can be used along with #chemotherapy or #surgery. Know more about the different #therapies used for the treatment of #cancer.

Join us at #Osaka this #October 15-16, 2018- #CancerTherapy2018 conference
https://tinyurl.com/yampyqa5 

Wednesday, May 16, 2018

Molecular Diagnostics - Session at Cancer Therapy 2018 conference

#MolecularDiagnostics involves the different tests to examine #DNA, #RNA and #Protein for #diagnosis, #prognosis and #prediction purposes. This new advanced technique can be used for various purposes like,
  • Risk Assessment
  • Differential Diagnosis
  • Prognosis
  • Prediction of Treatment Response
  • Pharmacokinetics
  • Monitoring Treatment Response
Know more about Molecular diagnostics and share your viewpoints and experiences related to diagnostics at the #CancerTherapy2018 conference.
https://tinyurl.com/y7ujk23z

Media Partner-Cancer Therapy 2018

https://tinyurl.com/yamgtlje 


 “We all do better when we work together” 

#CancerTherapy2018 is glad to have many reputed firms like Tabeeby, EXPO-Group,Conference Clocate, Vydya health, The Pharma Times, Medgadget , EventsGet and ManuscriptEdit as its media partners.

Join as for the conference, "3rd World Congress on Advanced & Therapy"during 15-16, 2018.

Tuesday, May 15, 2018

Oncogenomics-Track 2 at the Cancer Therapy 2018 conference


Oncogenomics is a subfield of genomics characterizing the genes that cause cancer. Three genes that are primarily responsible for cancer development are
i)          Oncogenes- In the case of cancer, these genes replace the protooncogenes responsible for normal cell growth and make the cells grow and divide rapidly forming cancer.
ii)         Tumor suppressor genes – In a cancerous patient, the tumor suppressor genes that inhibit cell division gets turned off and thus leading to the uncontrolled division of cells which further results in cancer
iii)        DNA repair genes –DNA mutations or damages in  DNA are repaired and controlled by these genes. A healthy cell turns into a cancerous one when these DNA repair genes get disabled or altered.

Monday, May 14, 2018

Cancer Therapy 2018- Conference Highlights

Lots of interesting sessions are open at the upcoming International conference on cancer, "3rd World Congress on Advanced Cancer Science & Therapy"scheduled at Osaka, Japan during October 15-16, 2018. https://tinyurl.com/y9g4jasd
 

 Cancer Therapy 2018 includes a number of highlights like Cancer Pathophysiology, Oncogeneomics, Operomics, Biomarkers and many more. Be a part of this worldwide event and present your ideas under the session of your interest in the form of oral or posters.

Radiation Therapy_Cancer Therapy 2018

#Radiationtherapy is the most primary #treatment given to #cancer patients of all types. To know more about the different #therapies admi...